מזומני החברה zurabio.com (ZURA)

Zura Bio Limited specializes in multi-target cytokine suppression for the therapy of rare inflammatory diseases. Growth potential is driven by trials of the ZB-168 drug against asthma, while antibody patents provide a defensive moat. This daily chart from the GURU.Markets platform reflects cash accumulation dynamics, where the value has stabilized at 0.19, confirming the financial stability of the biopharmaceutical business.
פילוחי נתונים אנליטיים מרוכזים עבור Zura Bio Limited (ZURA)

This metric is calculated as the sum of the most liquid balance sheet items, reflecting the volume of funds available for operational activities. This metric determines the business's financial autonomy and its resilience to rising borrowing costs. For Zura Bio (ZURA), given the conditions of early-stage clinical trials, this represents a critical reserve that mitigates capital shortage risks. By analyzing the cash position, an investor assesses the company's ability to sustain research without the urgent need for external financing.